Matesanz Ana I, Souza Pilar
Departamento de Química Inorgánica, Facultad de Ciencias, Universidad Autónoma de Madrid, C/Francisco Tomás y Valiente 7, 28049 Madrid, Spain.
J Inorg Biochem. 2007 Oct;101(10):1354-61. doi: 10.1016/j.jinorgbio.2007.05.013. Epub 2007 Jun 12.
The preparation of new palladium(II) and platinum(II) complexes derived from alpha-diphenyl ethanedione bis(thiosemicarbazone), 1, and alpha-diphenyl ethanedione bis(4-ethylthiosemicarbazone), 2, is described. The palladium complexes 3 and 4 and platinum complexes 5 and 6 have been characterized by elemental analyses, fast atom bombardment mass spectrometry (FAB(+)) and spectroscopic studies (IR, (1)HNMR). The crystal and molecular structures of the dimeric cyclopalladated compound 4 and the mononuclear platinum complex 6 have been determined by single crystal X-ray diffraction. The cytotoxic activity of the free ligands and palladium and platinum complexes against human A2780 and A2780cisR (acquired resistance to cisplatin) epithelial ovarian carcinoma cells lines is also reported. The IC(50) values for compounds 1, 5 and 6 were found to be higher than that of cisplatin but the maximum antiproliferative activity was similar. Furthermore, the compounds largely retain their activity in the A2780cisR cell line, having a much better resistance factor than cisplatin in the pair of cell lines tested.
本文描述了由α-二苯基乙二酮双(硫代半卡巴腙)(1)和α-二苯基乙二酮双(4-乙基硫代半卡巴腙)(2)衍生的新型钯(II)和铂(II)配合物的制备。通过元素分析、快原子轰击质谱(FAB(+))和光谱研究(红外光谱、(1)HNMR)对钯配合物3和4以及铂配合物5和6进行了表征。通过单晶X射线衍射确定了二聚环钯化化合物4和单核铂配合物6的晶体和分子结构。还报道了游离配体以及钯和铂配合物对人A2780和A2780cisR(对顺铂获得性耐药)上皮性卵巢癌细胞系的细胞毒性活性。发现化合物1、5和6的IC(50)值高于顺铂,但最大抗增殖活性相似。此外,这些化合物在A2780cisR细胞系中基本保留了其活性,在测试的细胞系对中具有比顺铂更好的耐药因子。